CXCL9 Protein

Catalog No. ABIN935628

This Recombinant CXCL9 protein is expressed in Escherichia coli (E. coli).

Quick Overview for CXCL9 Protein (ABIN935628)

Target: CXCL9 (gamma-Interferon-Induced Monokine (CXCL9))

Protein Type: Recombinant

Biological Activity: Active

Origin: Human

Source: Escherichia coli (E. coli)

Purity: > 98 % pure

Product Details

Sequence: TPVVRKGRCS CISTNQGTIH LQSLKDLKQF APSPSCEKIE IIATLKNGVQ TCLNPDSADV KELIKKWEKQ VSQKKKQKNG KKHQKKKVLK VRKSQRSRQK KTT

Characteristics: Purified recombinant Human MIG protein
Expression System: E.coli
Bioactivity: Determined by its ability to chemoattract human peripheral blood T lymphoytes using a concentration range of 10.0-100.0 ng/mL.

Endotoxin Level: < 0.1 ng per µg (1 EU/µg).

Application Details

Application Notes: Each Investigator should determine their own optimal working dilution for specific applications.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Reconstitution: Reconstitute in water to a concentration of 0.1-1.0 mg/mL. The solution canthen be diluted into other aqueous buffers.

Buffer: Supplied lyophilized with no additives.

Preservative: Without preservative

Handling Advice: Avoid repeated freeze/thaw cycles.

Storage: RT/-20 °C

Target Details

Target: CXCL9 (gamma-Interferon-Induced Monokine (CXCL9))

Alternative Name: MIG

Background: MIG, a CXC chemokine, is produced by IFN stimulated monocytes, macrophages and endothelial cells. It signals through the CXCR3 receptor. MIG selectively chemoattracts Th1 lymphocytes, and also exerts other activities including inhibition of tumor growth, angiogenesis, and inhibition of colony formation of hematopoietic progenitors. Human MIG is active on Mouse cells.
Alternative Names: CXCL9 protein, Monokine Induced by Interferon-gamma protein

Molecular Weight: 11.7 kDa